Aster International Pharmaceuticals LLP

Aster International Pharmaceuticals LLP - pharma in Navi Mumbai, Maharashtra, India. Directors, charges & compliance details.
LLPIN AAM-7850 Incorporated 07 June 2018 ROC Mumbai HQ Navi Mumbai, Maharashtra, India
Active Limited Liability Partnership pharma MSME · Micro
Data last updated
Contribution obligation
₹50,000
As per LLP agreement
Open charges
₹50 Lakh
Secured borrowings
LLP age
8 yrs
Est. 2018
Designated partners
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Mumbai
ROC office

About Aster International Pharmaceuticals LLP

Data last updated:

Aster International Pharmaceuticals LLP is a limited liability partnership (LLP) based in Navi Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 June 2018 and has been in existence for over 8 years.

The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAM-7850. Its GSTIN is 27ABMFA2544A1ZT (Maharashtra).

The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners including Simple Omprakash Samota and Ankit Jain.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Flat No. 301 Plot No. A – 68 Sector 10B Ulwe, Navi Mumbai, Maharashtra, India – 410206.

As per MCA filings, the LLP has open charges of ₹50 Lakh on record.

Aster International Pharmaceuticals LLP is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0020947).

Company details

LLPIN AAM-7850
Incorporation Date 07 June 2018
Total Obligation of Contribution ₹50,000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-27-0020947

Recognitions & Rankings of Aster International Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MH-27-0020947

Contact details

Aster International Pharmaceuticals LLP's registered office is in Navi Mumbai, Maharashtra.

  • Registered Address
    Flat No. 301 Plot No. A – 68 Sector 10B Ulwe, Navi Mumbai, Maharashtra, India – 410206
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Aster International Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Aster International Pharmaceuticals LLP

FY 2025 filings available

Financial Statement Summary

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
Net Profit Margin
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Aster International Pharmaceuticals LLP, buy the company report.

Designated partners of Aster International Pharmaceuticals LLP

Aster International Pharmaceuticals has 3 designated partners on record. No former designated partners are listed.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Simple Omprakash SamotaDesignated Partner07 Jun 20188 Years 4 MonthsCurrent
Ankit JainDesignated Partner07 Jun 20188 Years 4 MonthsCurrent
Nirmala Sherbahadur SonarDesignated Partner30 Mar 20242 Years 6 MonthsCurrent

Charges & borrowings

Open charges
₹50 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.50 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Jan 2024100871314Hdfc Bank Limited₹50 LakhOpen

To see the full charge records of Aster International Pharmaceuticals LLP, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aster International Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Aster International Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
27ABMFA2544A1ZTMaharashtraActive03 Aug 2018

To see the full GST registrations and return filing status of Aster International Pharmaceuticals LLP, buy the company report.

Recent activity

Aster International Pharmaceuticals LLP has 3 designated partner changes on record since 2018: 3 appointments. The latest: Nirmala Sherbahadur Sonar was appointed as Designated Partner on 30 Mar 2024.

AGM
Aster International Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Aster International Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited of Rs. 5,000,000.00 registered on 09 Jan 2024 with Charge ID 100871314 was modified on 25 Oct 2024.
Appointed
Nirmala Sherbahadur Sonar was appointed as Designated Partner.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5,000,000.00 with Charge ID 100871314 was registered on 09 Jan 2024.
Appointed
Ankit Jain was appointed as Designated Partner.
Appointed
Simple Omprakash Samota was appointed as Designated Partner.
Incorporation
07 Jun 2018
Aster International Pharmaceuticals Llp was registered on 07 Jun 2018 with Roc Mumbai & aged 8 years 4 months as per MCA records.

Frequently asked questions

Aster International Pharmaceuticals is an active limited liability partnership based in Navi Mumbai, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 June 2018 (8+ years old) and is registered under LLPIN AAM-7850.

Aster International Pharmaceuticals has 3 current designated partners:

The latest financial statements of Aster International Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Aster International Pharmaceuticals is 27ABMFA2544A1ZT, registered in Maharashtra.

The LLPIN (Limited Liability Partnership Identification Number) of Aster International Pharmaceuticals is AAM-7850. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aster International Pharmaceuticals was incorporated on 07 June 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.

Nirmala Sherbahadur Sonar was appointed as Designated Partner on 30 Mar 2024. Ankit Jain was appointed as Designated Partner on 07 Jun 2018. Simple Omprakash Samota was appointed as Designated Partner on 07 Jun 2018.

Yes, Aster International Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-27-0020947).

The registered office of Aster International Pharmaceuticals is at Flat No. 301 Plot No. A – 68 Sector 10B Ulwe, Navi Mumbai, Maharashtra, India – 410206.

Aster International Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.